ALNYLAM PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Earnings Per Share, Basic and Diluted of -$1.71 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-04-29
- ALNYLAM PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$1.71.
- ALNYLAM PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$2.09.
- ALNYLAM PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$2.18.
- ALNYLAM PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$1.56.
- ALNYLAM PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2020 was -$7.46.
- ALNYLAM PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2019 was -$8.11.
- ALNYLAM PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2018 was -$7.57.
- ALNYLAM PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2017 was -$5.42.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$1.71 10-Q · filed 2021-04-29 | -$3.80 derived: net income ÷ weighted average shares · filed 2022-10-27 | -$5.99 derived: net income ÷ weighted average shares · filed 2022-10-27 | -$7.55 derived: net income ÷ weighted average shares · filed 2022-10-27 |
| 2020-12-31 | -$2.09 10-K · filed 2021-02-11 | -$4.28 derived: net income ÷ weighted average shares · filed 2021-10-28 | -$5.84 derived: net income ÷ weighted average shares · filed 2021-10-28 | -$7.46 10-K · filed 2021-02-11 |
| 2020-09-30 | -$2.18 10-K · filed 2021-02-11 | -$3.75 derived: net income ÷ weighted average shares · filed 2021-10-28 | -$5.37 10-Q · filed 2020-11-05 | -$7.83 derived: net income ÷ weighted average shares · filed 2021-10-28 |
| 2020-06-30 | -$1.56 10-K · filed 2021-02-11 | -$3.18 10-Q · filed 2020-08-06 | -$5.64 derived: net income ÷ weighted average shares · filed 2021-10-28 | -$7.55 derived: net income ÷ weighted average shares · filed 2021-10-28 |
| 2020-03-31 | -$1.62 10-Q · filed 2021-04-29 | -$4.08 derived: net income ÷ weighted average shares · filed 2021-10-28 | -$6.00 derived: net income ÷ weighted average shares · filed 2021-10-28 | -$8.03 derived: net income ÷ weighted average shares · filed 2021-10-28 |
| 2019-12-31 | -$2.47 10-K · filed 2021-02-11 | -$4.40 derived: net income ÷ weighted average shares · filed 2021-02-11 | -$6.42 derived: net income ÷ weighted average shares · filed 2021-02-11 | -$8.11 10-K · filed 2021-02-11 |
| 2019-09-30 | -$1.92 10-K · filed 2021-02-11 | -$3.94 derived: net income ÷ weighted average shares · filed 2021-02-11 | -$5.63 10-Q · filed 2020-11-05 | -$7.75 derived: net income ÷ weighted average shares · filed 2021-02-11 |
| 2019-06-30 | -$2.02 10-K · filed 2021-02-11 | -$3.75 10-Q · filed 2020-08-06 | -$5.84 derived: net income ÷ weighted average shares · filed 2021-02-11 | -$8.25 derived: net income ÷ weighted average shares · filed 2021-02-11 |
| 2019-03-31 | -$1.73 10-K · filed 2021-02-11 | -$3.81 derived: net income ÷ weighted average shares · filed 2021-02-11 | -$6.24 derived: net income ÷ weighted average shares · filed 2021-02-11 | -$7.87 derived: net income ÷ weighted average shares · filed 2021-02-11 |
| 2018-12-31 | -$2.09 10-K · filed 2020-02-13 | -$4.53 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$6.15 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$7.57 10-K · filed 2021-02-11 |
| 2018-09-30 | -$2.43 10-K · filed 2020-02-13 | -$4.06 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$5.48 10-Q · filed 2019-10-31 | -$6.97 derived: net income ÷ weighted average shares · filed 2020-02-13 |
| 2018-06-30 | -$1.63 10-K · filed 2020-02-13 | -$3.04 10-Q · filed 2019-08-06 | -$4.52 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$5.87 derived: net income ÷ weighted average shares · filed 2020-02-13 |
| 2018-03-31 | -$1.41 10-K · filed 2020-02-13 | -$2.89 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$4.23 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$5.58 derived: net income ÷ weighted average shares · filed 2020-02-13 |
| 2017-12-31 | -$1.48 10-K · filed 2019-02-14 | -$2.82 derived: net income ÷ weighted average shares · filed 2019-02-14 | -$4.17 derived: net income ÷ weighted average shares · filed 2019-02-14 | -$5.42 10-K · filed 2020-02-13 |
| 2017-09-30 | -$1.34 10-K · filed 2019-02-14 | -$2.68 derived: net income ÷ weighted average shares · filed 2019-02-14 | -$3.93 10-Q · filed 2018-11-07 | -$5.25 derived: net income ÷ weighted average shares · filed 2019-02-14 |
| 2017-06-30 | -$1.34 10-K · filed 2019-02-14 | -$2.59 10-Q · filed 2018-08-02 | -$3.91 derived: net income ÷ weighted average shares · filed 2019-02-14 | -$5.12 derived: net income ÷ weighted average shares · filed 2019-02-14 |
| 2017-03-31 | -$1.25 10-K · filed 2019-02-14 | -$2.56 derived: net income ÷ weighted average shares · filed 2019-02-14 | -$3.78 derived: net income ÷ weighted average shares · filed 2019-02-14 | -$4.83 derived: net income ÷ weighted average shares · filed 2019-02-14 |
| 2016-12-31 | -$1.32 10-K · filed 2018-02-15 | -$2.53 derived: net income ÷ weighted average shares · filed 2018-02-15 | -$3.58 derived: net income ÷ weighted average shares · filed 2018-02-15 | -$4.79 10-K · filed 2019-02-14 |
| 2016-09-30 | -$1.21 10-K · filed 2018-02-15 | -$2.27 derived: net income ÷ weighted average shares · filed 2018-02-15 | -$3.48 10-Q · filed 2017-11-07 | -$4.54 derived: net income ÷ weighted average shares · filed 2018-02-15 |
| 2016-06-30 | -$1.05 10-K · filed 2018-02-15 | -$2.26 10-Q · filed 2017-08-09 | -$3.33 derived: net income ÷ weighted average shares · filed 2018-02-15 | -$4.24 derived: net income ÷ weighted average shares · filed 2018-02-15 |
| 2016-03-31 | -$1.21 10-K · filed 2018-02-15 | -$2.28 derived: net income ÷ weighted average shares · filed 2018-02-15 | -$3.18 derived: net income ÷ weighted average shares · filed 2018-02-15 | -$4.04 derived: net income ÷ weighted average shares · filed 2018-02-15 |
| 2015-12-31 | -$1.07 10-K · filed 2017-02-15 | -$1.98 derived: net income ÷ weighted average shares · filed 2017-02-15 | -$2.83 derived: net income ÷ weighted average shares · filed 2017-02-15 | -$3.45 10-K · filed 2018-02-15 |
| 2015-09-30 | -$0.91 10-K · filed 2017-02-15 | -$1.76 derived: net income ÷ weighted average shares · filed 2017-02-15 | -$2.38 10-Q · filed 2016-11-03 | -$2.69 derived: net income ÷ weighted average shares · filed 2017-02-15 |
| 2015-06-30 | -$0.85 10-K · filed 2017-02-15 | -$1.47 10-Q · filed 2016-08-04 | -$1.77 derived: net income ÷ weighted average shares · filed 2017-02-15 | -$2.35 derived: net income ÷ weighted average shares · filed 2017-02-15 |
| 2015-03-31 | -$0.62 10-K · filed 2017-02-15 | -$0.91 derived: net income ÷ weighted average shares · filed 2017-02-15 | -$1.48 derived: net income ÷ weighted average shares · filed 2017-02-15 | -$2.06 derived: net income ÷ weighted average shares · filed 2017-02-15 |
| 2014-12-31 | -$0.28 10-K · filed 2016-02-12 | -$0.85 derived: net income ÷ weighted average shares · filed 2016-02-12 | -$1.43 derived: net income ÷ weighted average shares · filed 2016-02-12 | -$4.85 10-K · filed 2017-02-15 |
| 2014-09-30 | -$0.58 10-K · filed 2016-02-12 | -$1.16 derived: net income ÷ weighted average shares · filed 2016-02-12 | -$4.62 10-Q · filed 2015-11-09 | -$5.25 derived: net income ÷ weighted average shares · filed 2016-02-12 |
| 2014-06-30 | -$0.58 10-K · filed 2016-02-12 | -$4.11 10-Q · filed 2015-08-07 | -$4.76 derived: net income ÷ weighted average shares · filed 2016-02-12 | -$5.31 derived: net income ÷ weighted average shares · filed 2016-02-12 |
| 2014-03-31 | -$3.70 10-K · filed 2016-02-12 | -$4.34 derived: net income ÷ weighted average shares · filed 2016-02-12 | -$4.86 derived: net income ÷ weighted average shares · filed 2016-02-12 | -$5.20 derived: net income ÷ weighted average shares · filed 2016-02-12 |
| 2013-12-31 | -$0.51 10-K · filed 2015-02-13 | -$0.99 derived: net income ÷ weighted average shares · filed 2015-02-13 | -$1.29 derived: net income ÷ weighted average shares · filed 2015-02-13 | -$1.45 10-K · filed 2016-02-12 |
| 2013-09-30 | -$0.48 10-K · filed 2015-02-13 | -$0.77 derived: net income ÷ weighted average shares · filed 2015-02-13 | -$0.93 10-Q · filed 2014-11-06 | -$2.03 derived: net income ÷ weighted average shares · filed 2015-02-13 |
| 2013-06-30 | -$0.29 10-K · filed 2015-02-13 | -$0.45 10-Q · filed 2014-08-08 | -$1.55 derived: net income ÷ weighted average shares · filed 2015-02-13 | -$1.94 derived: net income ÷ weighted average shares · filed 2015-02-13 |
| 2013-03-31 | -$0.15 10-K · filed 2015-02-13 | -$1.28 derived: net income ÷ weighted average shares · filed 2015-02-13 | -$1.67 derived: net income ÷ weighted average shares · filed 2015-02-13 | -$1.94 derived: net income ÷ weighted average shares · filed 2015-02-13 |
| 2012-12-31 | -$1.20 10-K · filed 2014-02-20 | -$1.58 derived: net income ÷ weighted average shares · filed 2014-02-20 | -$1.84 derived: net income ÷ weighted average shares · filed 2014-02-20 | -$2.11 10-K · filed 2015-02-13 |
| 2012-09-30 | -$0.38 10-K · filed 2014-02-20 | -$0.63 derived: net income ÷ weighted average shares · filed 2014-02-20 | -$0.88 10-Q · filed 2013-11-07 | -$1.21 derived: net income ÷ weighted average shares · filed 2014-02-20 |
| 2012-06-30 | -$0.25 10-K · filed 2014-02-20 | -$0.50 10-Q · filed 2013-08-09 | -$0.83 derived: net income ÷ weighted average shares · filed 2014-02-20 | -$1.13 derived: net income ÷ weighted average shares · filed 2014-02-20 |
| 2012-03-31 | -$0.25 10-K · filed 2014-02-20 | -$0.58 derived: net income ÷ weighted average shares · filed 2014-02-20 | -$0.89 derived: net income ÷ weighted average shares · filed 2014-02-20 | -$1.21 derived: net income ÷ weighted average shares · filed 2014-02-20 |
| 2011-12-31 | -$0.33 10-K · filed 2013-02-19 | -$0.65 derived: net income ÷ weighted average shares · filed 2013-02-19 | -$0.97 derived: net income ÷ weighted average shares · filed 2013-02-19 | -$1.36 10-K · filed 2014-02-20 |
| 2011-09-30 | -$0.31 10-K · filed 2013-02-19 | -$0.64 derived: net income ÷ weighted average shares · filed 2013-02-19 | -$1.02 10-Q · filed 2012-11-05 | |
| 2011-06-30 | -$0.33 10-K · filed 2013-02-19 | -$0.71 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | -$0.38 10-K · filed 2013-02-19 | |||
| 2010-12-31 | -$1.04 10-K · filed 2013-02-19 | |||
| 2010-09-30 | -$0.23 10-Q · filed 2011-11-03 | -$0.87 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$0.35 10-Q · filed 2011-08-03 | -$0.64 10-Q · filed 2011-08-03 | ||
| 2009-12-31 | -$1.14 10-K · filed 2012-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |